LifeStance Health Group, Inc. — Q3 2026 Earnings Summary

LifeStance Health Group reported third-quarter 2026 revenue of $455.9 million, representing a 25% increase from the prior year, driven by a 17% rise in visit volumes and an 11% expansion of its clinician base to 8,863 providers. The company achieved net income of $22.4 million and Adjusted EBITDA of $68.4 million, while generating $22.4 million in free cash flow for the quarter. Based on this performance, LifeStance raised its full-year 2026 outlook, projecting revenue between $1.741 billion and $1.761 billion, Center Margin between $599 million and $613 million, and Adjusted EBITDA between $242 million and $250 million.